維護健康 關愛生命 二零零八年度報告
C-12 蛋白芯片 C-12 1
目錄 2 3 6 10 16 31 33 34 40 47 48 49 50 51 53 103 104
使命 2
2,000 5,800 760 13% 170 1,000 1,500 1,000 300 1. 2. 58 13.12 3. 11.2% 22.6% 20.4% 13.7% 13% 21.9% 5,800 760 13% 130 100 662,000 655,000 502,000 70% 900 1,140 40%
1. 2. http://www.health-alliance.com/cancer/cancer.html 2,993 28% 5,086 85% 8,890 61% 9,002 94% 2,422 58% 10,242 86%
C-12 產品介紹 何謂腫瘤標誌物? C-12 C-12: 一個符合經濟效益的有效癌症篩查方法 (1) (2) (3) (4) 何謂 C-12? (C-12)12 C-12 C-1212 (CT Scan) (MRI) (Ultrasound Scan) (PET Scan) (Endoscopy) (Biopsies) 3
HPV DNA 何謂 hpv? HPV 80% HPV 70% 91% HPV 100HPVHPV 13 HPV16/18/31/33/35/39/45/51/52/56/58/59/68 為何本集團的 hpv dna 測試是檢測子宮頸癌的早期測試? 60Pap Test 50% 70% HPV HPVHPV HPV 何謂子宮頸? 何謂子宮頸癌? 80% PCRHPV DNA PCR DNA DNA 95% hpv 疫苗有何重要性? HPV6 11 16 18 HPV 16 18 6 11HPVHPV 4 4
產品介紹 HPV HPV 6 11 16 18 HPV HPV DNAHPV 70% 30% HPV HPV 子宮頸癌的常用治療方法 : 子宮頸癌的常用診斷方法 : CAT 5
公司資料 董事局 主要往來銀行 主要股份過戶登記處 Butterfield Corporate Services Limited 65 Front Street, Hamilton, Bermuda 審核委員會 香港股份過戶登記處 授權代表 公司秘書 註冊辦事處 Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda 主要營業地點 10 1801-03 (852) 3102 3201 (852) 3102 0905 mingyuan@mingyuan-hk.com www.mymedicare.com.hk 核數師 股票上市場所 法律顧問 股份代號 233 233.HK 233 HK 6
C-12 C-12 C-12 LU-07 LU-07 C-12 7
及早檢測拯救生命 癌症 58 及早檢測拯救性命 8
全球抗癌運動 58 9 58
主席報告 8,500 C-12 KM2003 引言 C-12 HPV DNA 10
主席報告 ( 續 ) 業績 業務回顧 27.1% 326,000,000256,400,000 C-12C-12 150,800,000 126,800,000 18.9% 5.134.48 C-12 C-12 HPV DNA 290,500,000 219,000,000 32.6% 13.0% 207,400,000 183,400,000 35,500,000 37,400,000 2,700,000 581,000 HPV DNA 118 880 C-12 11
主席報告 ( 續 ) 展望 IVD IVD PMD MCM MCM PMD MCM 2,000 1,000 700 1,500 1,000 12
主席報告 ( 續 ) KM2003 KM2003 KM2003 PIP DNALIP PIP LIP PIP C-12C-12A C-12A LIP HPV DNA 28.8 505 (PCR) HPV DNA PCR DNA 95% Harald zur Hausen HPV DNA C-12C-6 C-6 HPV DNA 20 13
主席報告 ( 續 ) Bill & Melinda Gates Foundation 10 10 Bill & Melinda Gates Foundation 3,300 14% 22% 130,000 309 50 公司管治及投資關係策略 KM2003 14
主席報告 ( 續 ) 240 (71%)(15%) (10%) (2%) (2%) 37 161 100 35 結論 8,500 C-12 HPV DNAC-6 15
16 管理層討論與分析市場回顧 9.0% 88.1% 10.8% 8% 8,500 16% 2,729 8.14 91.5% 9.9% 6.4% 15,781 4,761 8.4% 8.0% 11.0% 15.4%
管理層討論與分析 ( 續 ) 4.7% 37,800,000 317,000,000 279,200,00029% 43% 47% 業務回顧 HPV DNA C-12 C-12HPV DNA CEA C-6 17
管理層討論與分析 ( 續 ) Luminex Corporation Luminex Corporation xmap 75% 400,000 2008 C-12 C-12 12 10C-12 C-12 C-12 C-12 2.8 2.2 27.3% 8,800,000 PIP 18
管理層討論與分析 ( 續 ) C-6 192 C-12 4,000 C-12 C-12 C-12 40% C-12 C-12 C-6 HPV DNA 19
管理層討論與分析 ( 續 ) 435 406 C-12C-12 51% HPV DNA DNA 48 24 16 42 18 10 18 10 C-12 HPV DNA (>95%) 50 60% 288,000 500,000 50,000 130,000 300,000,000 HPV DNA HPV 18 20
管理層討論與分析 ( 續 ) 財務業績 150,100,000 125,300,00019.8% 5.13 4.48 14.5% HPV DNA 38,000 25,000HPV DNA 118 C-12290,500,000 219,000,000 32.6% 207,500,000 183,400,000 13.1% 2,800,000 2,200,00027.3% 35,600,000 37,400,0002,700,000 581,000 51% 前景 4 8,500 21
22 管理層討論與分析 ( 續 ) KM2003 C-12 118 HPV DNA 58 80% KM2003 PMD MCM
管理層討論與分析 ( 續 ) PMD MCM PMD KM2003 (1) 400 C-12 81,764800 C-12150 C-12 C-12 C-12 (3) (2) 45700 C-121,000 C-12 40 C-12 23
管理層討論與分析 ( 續 ) HPV DNA PCR 2,000 HPV DNA HPV DNA HPV DNA CEA CEA CEAC-12 (4) 24
管理層討論與分析 ( 續 ) PIP LIP PIP LIP LIP20 SNIPER TM HPV DNA 309 50 (5) HPV DNA 25
管理層討論與分析 ( 續 ) X Chalfont St. Giles 3,000 20,000,000 Luminex xmap 100 Luminex Luminex xmap Luminex Corporation Luminex Luminex xmap 26
管理層討論與分析 ( 續 ) (6) PIP LIP C-6 C-6 C-6 CA19-9 AFP CEA CA125 SCC CK19 C-6 C-6 C-6 C-6 20 Bill & Melinda Gates Foundation 10 10 27
管理層討論與分析 ( 續 ) C12 C12A C-12A C-12A C-12 C-12 12C12A C12A C-12AFP CEA CA19-9 CA125 CA242 CA15-3 HCG NSE SCC CK19 CA72-4 c-psa C-12A C-12A RAD 3 5% Auto RAD 5,000 ISD ISD 2,000 MCM MCM MCM MCM 75% 28
29 管理層討論與分析 ( 續 ) (3) (2) 12 400,000 MCM 10% 4.6% 8,500 末期股息 0.01
管理層討論與分析 ( 續 ) 資產抵押 43,728 42,500 172,464 169,721 81,160 2,385 14,429 16,923 316,660 226,650 流動資金及融資 619,800,000 453,500,000 237,200,000 192,900,000 1,014,900,000 827,400,000 23.4% 23.3% 199,900,000 138,100,000 1.856.34 或然負債 30
董事簡介 姚原先生 胡軍先生 53 67 39 姚湧先生 余惕君先生 51 HD Global LimitedHD Global HD Global 錢禹銘先生 57 45 20 31
董事簡介 ( 續 ) 楊振華先生 林家禮博士 73 100 馬永偉先生 66 35 49 26 胡錦華先生 66 40 李思浩先生 40 20 32
高級管理層簡介 劉源新先生 潘光偉先生 54 27 陸錫強先生 47. 王斌先生 41 52 柳飛舟博士 47 林世健先生 41 17 33
企業管治報告 企業管治常規 董事局 34
企業管治報告 ( 續 ) 6/6 6/6 1/1 6/6 6/6 6/6 3/3 3/3 6/6 2/2 1/1 6/6 2/2 6/6 2/2 1/1 35
企業管治報告 ( 續 ) 主席及首席執行官 董事 A.4.1 109 A.4.2 3.13 36
企業管治報告 ( 續 ) 董事委員會 (a) (b) (c) 37
企業管治報告 ( 續 ) 內部監控 證券交易行為守則 38
企業管治報告 ( 續 ) 核數師酬金 1,800,0001,600,000 690,000192,600 股東權利與投資者關係 www.mymedicare.com.hk 39
董事局報告 主要業務 42 業績及分派 48 物業 機器及設備 16 股本 29 本公司可供分派儲備 (i) (ii) 48,967,000 40
董事局報告 ( 續 ) 主要客戶及供應商 47% 18% 57%43% 5% 董事 董事服務合約 41
董事局報告 ( 續 ) 董事之股份權益 352 (a) 0.05 966,079,075 (i) 32.92% 123,355,263 (i) 4.26% 999,419,075 (ii) 34.06% 123,355,263 (ii) 4.26% (i) Ming Yuan Holdings Limited Ming Yuan Investments Group LimitedMing Yuan Holdings Limited50% 50% (ii) 33,340,000 Ming Yuan Investments Group Limited 966,079,075 (b) 26,500,000 26,500,000 10,000,000 10,000,000 12,400,000 12,400,000 2,400,000 2,400,000 42
董事局報告 ( 續 ) 購股權 33 0.728 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 5,300,000 26,500,000 26,500,000 0.728 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 10,000,000 10,000,000 0.728 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 0.78 800,000 800,000 800,000 800,000 800,000 800,000 12,400,000 12,400,000 0.78 800,000 800,000 800,000 800,000 800,000 800,000 2,400,000 2,400,000 51,300,000 51,300,000 0.728 1,200,000 (600,000) 600,000 3,400,000 (800,000) 2,600,000 11,500,000 (4,700,000) 6,800,000 16,900,000 (2,500,000) 14,400,000 16,900,000 16,900,000 0.78 3,800,000 (900,000) 2,900,000 7,060,000 7,060,000 7,060,000 7,060,000 67,820,000 (9,500,000) 58,320,000 119,120,000 (9,500,000) 109,620,000 43
董事局報告 ( 續 ) 購買股份或債券安排 董事之重大合約權益 主要股東 336 Ming Yuan Investments Group Limited 966,079,075 (i) 32.92% Ming Yuan Holdings Limited 966,079,075 (i) 32.92% 966,079,075 (i) 32.92% 999,419,075 (i) (ii) 34.06% Highbridge International LLC 153,513,513 (iii) 5.23% Highbridge Master L.P. 153,513,513 (iii) 5.23% Highbridge Asia Opportunities Master L.P. 153,513,513 (iii) 5.23% Highbridge G.P., Ltd. 153,513,513 (iii) 5.23% Clive Harris 153,513,513 (iii) 5.23% Richard Crawshaw 153,513,513 (iii) 5.23% NaZareth Group Limited 628,309,075 (iv) 21.41% Provider Pacific Holdings Limited 628,309,075 (iv) 21.41% FMR LLC 234,370,000 (v) 7.99% FMR Co 224,950,000 (v) 7.67% Fidelity Management & Research Company 224,950,000 (v) 7.67% 44
董事局報告 ( 續 ) Ming Yuan Investments Group Limited 123,355,263 (i) 4.20% Ming Yuan Holdings Limited 123,355,263 (i) 4.20% 123,355,263 (i) 4.20% 123,355,263 (i) (ii) 4.20% (i) Ming Yuan Holdings Limited Ming Yuan Investments Group LimitedMing Yuan Holdings Limited 50% (ii) 33,340,000 Ming Yuan Investments Group Limited 966,079,075 (iii) 153,513,513Highbridge Master L.P. Highbridge International LLCHighbridge Master L.P. Highbridge Asia Opportunities Master L.P.Highbridge Asia Opportunities Master L.P. Highbridge GP Ltd. Highbridge GP Ltd. Clive Harries Richard Crawshaw 50% 50% Highbridge Master L.P. Highbridge Asia Opportunities Master L.P. Highbridge GP Ltd. Clive Harries Richard Crawshaw153,513,513 (iv) 628,309.075NaZareth Group Limited Provider Pacific Holdings LimitedNaZareth Group Limited 628,309,075 (v) Fidelity Management & Research Company 224,950,000Fidelity Management Trust Company, Pyramis Global Advisors LLC 9,420,000 Fidelity Management & Research Company FMR Co FMR Co FMR LLC Fidelity Management Trust Company, Pyramids Global Advisors LLC FMC & Pyramis FMC & Pyramis FMR LLC 5% 委任獨立非執行董事 3.13 45
董事局報告 ( 續 ) 薪酬政策 33 足夠公眾持股量 優先購買權 結算日後事項 41 核數師 46
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 獨立核數師報告 48 102 董事就綜合財務報表須承擔的責任 核數師的責任 90 意見 47
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合損益帳 截至二零零八年十二月三十一日止年度 7 326,066 256,474 (62,070) (42,992) 263,996 213,482 9 20,702 30,748 (23,250) (15,921) (53,735) (49,502) (18,534) (19,068) 10 (12,894) (9,624) 34 178 176,285 150,293 11 (25,440) (23,411) 12 150,845 126,882 150,102 125,282 743 1,600 150,845 126,882 14 29,346 56,214 15 5.13 4.48 5.06 4.30 48
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合資產負債表 於二零零八年十二月三十一日 16 358,175 326,351 17 71,150 69,945 18 104,240 104,240 19 2,274 2,088 20 528 528 21 56,410 22 21,670 23,297 614,447 526,449 17 1,569 1,509 23 18,585 14,222 24 124,436 80,809 20 2,467 25,189 25 16,923 25 602,917 453,514 766,897 575,243 26 58,104 47,714 27 29,217 6,209 28 87,077 68,229 10,135 16,783 184,533 138,935 582,364 436,308 1,196,811 962,757 29 146,731 144,904 868,193 682,535 1,014,924 827,439 5,106 4,363 1,020,030 831,802 28 112,820 69,916 30 37,268 54,761 31 26,693 6,278 176,781 130,955 1,196,811 962,757 48 102 49
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合股權變動表 截至二零零八年十二月三十一日止年度 134,405 150,354 20,343 14,761 12,804 34,485 47 200,895 568,094 2,763 570,857 44,585 44,585 44,585 125,282 125,282 1,600 126,882 (47) (47) (47) 44,585 (47) 125,282 169,820 1,600 171,420 5,388 5,388 5,388 9,797 145,187 (14,749) 140,235 140,235 1,893 30,957 (5,118) 27,732 27,732 (2,499) 2,499 (1,191) (26,425) (27,616) (27,616) (56,214) (56,214) (56,214) 144,904 300,073 5,594 12,532 12,804 79,070 272,462 827,439 4,363 831,802 38,607 38,607 38,607 150,102 150,102 743 150,845 38,607 150,102 188,709 743 189,452 1,815 1,815 1,815 1,352 20,026 (2,034) 19,344 19,344 475 7,719 (1,231) 6,963 6,963 (29,346) (29,346) (29,346) 146,731 327,818 3,560 13,116 12,804 117,677 393,218 1,014,924 5,106 1,020,030 50
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合現金流量表 截至二零零八年十二月三十一日止年度 176,285 150,293 12,894 9,624 1,815 5,388 (6,538) (5,217) 18,716 6,261 1,564 1,473 146 121 (6,565) (17,764) 167 (178) 3,343 198,317 153,511 (4,363) (6,762) 22,722 (25,189) (31,194) (30,364) 8,411 2,307 193,893 93,503 (11,043) (8,842) (11,673) (19,954) 171,177 64,707 6,538 5,217 (56,410) (35,114) (86,714) (16,923) 10,000 (234) (16,427) 223 29,683 34 182 204 (101,920) (57,855) 51
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合現金流量表 ( 續 ) 截至二零零八年十二月三十一日止年度 (29,346) (56,214) 6,963 27,732 (27,616) 96,205 93,520 (38,548) (53,738) 23,008 (5,532) 58,282 (21,848) 127,539 (14,996) 453,514 441,561 21,864 26,949 602,917 453,514 52
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 截至二零零八年十二月三十一日止年度 1. 一般資料 42 2. 採用新訂及經修訂香港財務報告準則 ( 香港財務報告準則 ) 39 7 11 12 14 2 19 53
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 2. 採用新訂及經修訂香港財務報告準則 ( 香港財務報告準則 )( 續 ) 1 1 2 23 2 27 3 32 1 2 39 3 127 2 2 2 3 3 7 2 8 2 9 4 39 13 5 15 2 16 6 17 3 18 7 1 5 2 3 4 5 6 7 3 27 54
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 3 5 55
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 56
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 57
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 58
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 59
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 60
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 61
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 62
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 63
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 64
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 3. 重大會計政策 ( 續 ) 4. 估計不明朗因素的主要來源 3 18 101,348,000 2,211,00075,094,000 3,261,000 65
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 5. 資金風險管理 28 30 6. 金融工具 6a. 114,024 75,619 16,923 602,917 453,514 733,864 529,133 2,467 25,189 528 528 736,859 554,850 28,534 23,347 29,217 6,209 199,897 138,145 37,268 54,761 294,916 222,462 66
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 6. 金融工具 ( 續 ) 6b. (i) 220 274,383 6,087 25,306 38,000 57,625 5% 5%5% 5% 5% 5% 5% 5% 5% 1,323 (9,983) 67
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 6. 金融工具 ( 續 ) 6b. (ii) 25 28 30 50 50 821,000 993,000 47,858,000 46,469,000 68
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 6. 金融工具 ( 續 ) 6b. 1 1 3 3 1 1 5 % 3,391 4,225 20,918 28,534 28,534 6.8 350 39,694 40,044 37,268 5.1 38,421 50,663 133,440 222,524 199,897 29,217 29,217 29,217 32,608 42,646 71,931 173,134 320,319 294,916 1 1 3 3 1 1 5 % 4,147 1,877 17,323 23,347 23,347 6.8 550 62,925 63,475 54,761 6.6 1,634 69,506 88,840 159,980 138,145 6,209 6,209 6,209 11,990 1,877 87,379 151,765 253,011 222,462 69
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 6. 金融工具 ( 續 ) 6c. 7. 收益 290,512 219,031 35,554 37,443 326,066 256,474 8. 分類資料 70
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 8. 分類資料 ( 續 ) 290,512 35,554 326,066 207,478 2,722 210,200 (13,237) 6,538 (14,322) (12,894) 176,285 (25,440) 150,845 219,031 37,443 256,474 183,401 581 183,982 (19,387) 5,217 (10,073) (9,624) 178 150,293 (23,411) 126,882 71
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 8. 分類資料 ( 續 ) 479,663 108,336 587,999 47,115 57,125 104,240 689,105 1,381,344 36,360 18,127 54,487 306,827 361,314 409,895 102,844 512,739 47,115 57,125 104,240 484,713 1,101,692 24,783 21,467 46,250 223,640 269,890 72
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 8. 分類資料 ( 續 ) 34,991 3,014 8 38,013 17,544 1,117 55 18,716 6,565 6,565 1,815 1,815 930 634 1,564 146 146 81,784 16,592 84 98,460 17,764 17,764 5,091 1,114 56 6,261 3,343 3,343 5,388 5,388 861 612 1,473 121 121 90% 73
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 9. 其他收入 6,538 5,217 6,565 17,764 4,970 6,301 2,629 1,466 20,702 30,748 10. 財務費用 10,494 6,843 2,400 3,567 12,894 10,410 (786) 12,894 9,624 1,610,400 11. 所得稅 13,312 25,735 (8,287) 31 20,415 (2,324) 25,440 23,411 74
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 11. 所得稅 ( 續 ) 2008 17.5% 16.5%16.5% 17.5% 33% 25% 20,555,000 176,285 150,293 25% 33% i 44,071 49,597 (3,154) (2,357) 6,772 10,527 (34,377) (31,996) (2,085) iii (8,287) 20,555 (140) (275) 25,440 23,411 75
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 11. 所得稅 ( 續 ) (i) (ii) 35,405,000 35,405,000 (iii) 18%50% 18% 9% 8,287,000 13.5%9% 12. 年度溢利 18,716 6,261 3,343 1,564 1,473 146 121 13(i) 5,650 6,198 28,204 27,224 1,308 4,151 270 115 35,432 37,688 1,800 1,600 14,322 10,073 62,070 42,992 1,122 167 4,066 4,409 (5) (28) 76
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 13. 董事及僱員酬金 (i) (a) 1,274 1,284 905 845 120 120 1,010 1,076 3,309 3,325 (b) 120 120 120 120 120 120 360 360 (c) 61 61 122 3,791 3,685 77
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 13. 董事及僱員酬金 ( 續 ) (i) (a) 526 516 790 724 1,316 1,240 (b) 12 12 12 12 12 12 36 36 (c) 127 315 48 119 190 461 365 895 1,717 2,171 (a) 142 342 5,650 6,198 78
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 13. 董事及僱員酬金 ( 續 ) (ii) 964 964 24 24 84 270 1,072 1,258 1,000,000 2 2 14. 股息 0.010.01 29,346 27,124 0.01 29,090 29,346 56,214 0.01 29,258 0.01 79
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 15. 每股盈利 150,102 125,282 2,400 3,567 152,502 128,849 2,928,747,984 2,797,888,233 35,081,213 28,697,405 51,406,886 170,751,722 3,015,236,083 2,997,337,360 80
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 16. 物業 機器及設備 12,446 29,269 2,312 4,232 3,203 978 194,812 247,252 590 2,154 147 885 115 56 14,336 18,283 20,027 599 2,432 586 74,816 98,460 164,240 17,616 (181,856) (11) (11) (15,691) (1,023) (391) (60) (17,165) 177,276 53,375 2,024 7,158 3,318 1,560 102,108 346,819 9,221 3,775 245 727 113 183 5,669 19,933 18,495 134 893 23 765 17,703 38,013 (2,289) 2,515 (226) (4,224) (1) (425) (97) (4,747) 184,208 73,936 2,402 8,353 3,454 2,411 125,254 400,018 1,163 10,603 1,843 2,157 1,668 306 17,740 86 780 116 730 3 5 1,720 983 3,846 258 823 104 247 6,261 (7) (7) (4,019) (901) (271) (55) (5,246) 2,232 11,210 1,309 3,439 1,775 503 20,468 585 1,561 232 537 38 129 3,082 7,801 9,219 235 1,036 109 316 18,716 (8) 8 (333) (90) (423) 10,610 21,998 1,776 4,679 1,922 858 41,843 173,598 51,938 626 3,674 1,532 1,553 125,254 358,175 175,044 42,165 715 3,719 1,543 1,057 102,108 326,351 81
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 16. 物業 機器及設備 ( 續 ) 5% 10% 30% 15% 50% 15% 33% 10% 33% 20% 33% 17. 預付租金 1,569 1,509 71,150 69,945 72,719 71,454 28,990,000 28,954,000 82
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 18. 商譽 104,240 8 47,115 57,125 104,240 15% 15% 2% 9.5% 9.5% 83
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 19. 無形資產 5,190 448 (3,343) 2,295 332 2,627 86 121 207 146 353 2,274 2,088 20 HPVHPV DNA 20 20 84
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 20. 可供出售投資 持作買賣投資 528 528 2,467 25,189 5% 21. 收購附屬公司所付按金 310,000,000 349,742,000 75%50,000,000 56,410,000 22. 購入物業 機器及設備所付按金 23. 存貨 14,554 8,761 1,684 3,439 2,347 2,022 18,585 14,222 85
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 24. 應收帳款及其他應收款項 按金及預付款項 103,559 78,355 (2,211) (3,261) 101,348 75,094 12,433 243 525 8,534 2,993 1,878 2,197 124,436 80,809 30 270 0 60 77,044 68,766 61 90 16,987 6,328 91 180 6,049 181 270 1,268 101,348 75,094 75,094,000 86
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 24. 應收帳款及其他應收款項 按金及預付款項 ( 續 ) 3,261 1,960 72 179 1,122 (963) (159) 2,211 3,261 25. 已抵押銀行存款與銀行結存及現金 4.14 2.07 0.50 0.72 0.72 2.04 220 6,087 274,383 25,306 87
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 26. 應付帳款及其他應付款項 7,616 6,215 7,407 3,833 21,302 17,022 13,511 13,299 4,263 5,076 4,005 2,269 58,104 47,714 0 60 6,831 6,014 61 90 295 9 90 490 192 7,616 6,215 27. 應付關連公司款項 29,217 6,209 88
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 28. 銀行借貸 161,897 80,520 38,000 57,625 199,897 138,145 87,077 68,229 33,846 16,236 78,974 53,680 199,897 138,145 (87,077) (68,229) 112,820 69,916 1.808.51 4.868.42 38,000 57,625 96,205,00093,520,0001 3 89
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 29. 股本 0.05 4,000,000,000 200,000 0.05 2,688,107,099 134,405 195,932,426 9,797 37,860,000 1,893 (23,810,000) (1,191) 2,898,089,525 144,904 27,027,026 1,352 9,500,000 475 2,934,616,551 146,731 30 27,027,0269,500,0000.05 0.05 6,620,000 1.1808 1.1281 7,685 5,910,000 1.1867 1.1600 6,944 5,810,000 1.1806 1.1400 6,757 5,470,000 1.1600 1.1300 6,230 23,810,000 27,616 90
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 30. 可換股債券 200,000,000 1% 1%0.74 15 0.05 113.41% 20,000,000144,990,000 0.05 6.77% 54,761 193,428 (19,344) (140,235) 2,400 3,567 (549) (1,999) 37,268 54,761 91
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 31. 遞延稅項負債 8,602 8,602 (2,085) (2,085) (239) (239) 6,278 6,278 20,555 (140) 20,415 20,555 6,138 26,693 92
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 32. 本公司之資產負債表 20 67 588,625 606,267 2,385 24,761 7,144 2,668 400 18,720 598,574 652,483 4,062 1,313 72,797 73,134 3,205 8,000 37,268 54,761 114,127 140,413 484,447 512,070 146,731 144,904 337,716 367,166 484,447 512,070 93
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 32. 本公司之資產負債表 ( 續 ) 150,354 20,343 14,761 12,804 (96,845) 101,417 186,723 186,723 145,187 (14,749) 130,438 30,957 (5,118) 25,839 (2,499) 2,499 5,388 5,388 (26,425) (26,425) (56,214) (56,214) 300,073 5,594 12,532 12,804 36,163 367,166 (26,399) (26,399) 20,026 (2,034) 17,992 7,719 (1,231) 6,488 1,815 1,815 (29,346) (29,346) 327,818 3,560 13,116 12,804 (19,582) 337,716 33. 購股權 10 109,620,000 119,120,000 3.74% 4.11% 10% 1% 94
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 33. 購股權 ( 續 ) 28 1 (i)(ii)(iii) 0.728 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 0.78 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 51,300,000 51,300,000 0.728 1,200,000 (600,000) 600,000 3,400,000 (800,000) 2,600,000 11,500,000 (4,700,000) 6,800,000 16,900,000 (2,500,000) 14,400,000 16,900,000 16,900,000 0.78 3,800,000 (900,000) 2,900,000 7,060,000 7,060,000 7,060,000 7,060,000 67,820,000 (9,500,000) 58,320,000 119,120,000 (9,500,000) 109,620,000 74,760,000 95
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 33. 購股權 ( 續 ) 0.728 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 9,300,000 0.78 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 1,600,000 46,500,000 4,800,000 51,300,000 0.728 18,100,000 (15,700,000) (1,200,000) 1,200,000 18,100,000 (13,500,000) (1,200,000) 3,400,000 16,900,000 (5,400,000) 11,500,000 16,900,000 16,900,000 16,900,000 16,900,000 0.78 7,060,000 (3,260,000) 3,800,000 7,060,000 7,060,000 7,060,000 7,060,000 86,900,000 21,180,000 (37,860,000) (2,400,000) 67,820,000 133,400,000 25,980,000 (37,860,000) (2,400,000) 119,120,000 49,400,000 96
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 33. 購股權 ( 續 ) 0.210.22 1.262 0.78 44.42% 1 3 4% 2.61% 3 1,815,000 5,388,000 1.24 1.32 97
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 34. 出售附屬公司 200,000 Hong Lan International Trading (Shanghai) LimitedHong Lan Hong Lan Hong Lan 4 18 178 22 200 200 200 (18) 182 Hong Lan 35. 承擔 89,568 94,505 293,332 382,900 94,505 98
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 36. 經營租約承擔 1,678,000 1,600,000 2,104 3,369 523 2,441 2,627 5,810 37. 或然負債 38. 退休福利計劃 306,000 151,000 23,000 99
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 39. 資產抵押 43,728 42,500 172,464 169,721 81,160 2,385 14,429 16,923 316,660 226,650 40. 關連人士披露 462,000 211,000 60,000,000 5,151 5,039 72 72 832 1,785 6,055 6,896 27 100
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 41. 結算日後事項 (i) 2175% (ii) 232,572,000 60,136,000 571,231,780 0.05 16.3% (iii) 280,000,000 (BVI)(BVI) 95% (BVI)DNA 101
Mingyuan Medicare Development Company Limited 二零零八年年報 Annual Report 2008 綜合財務報表附註 ( 續 ) 截至二零零八年十二月三十一日止年度 42. 主要附屬公司詳情 MY Technology Limited 1 100% HD Global Limited 100% 2,000,000 100% i 40,000,000 100% i 10,000,000 100% i 29,800,000 51% iii 15,000,000 51% ii (i) (ii) (iii) 102
Mingyuan Medicare Development 二零零八年年報 Company Limited Annual Report 2008 財務摘要 (a) 業績 523,568 126,985 160,835 256,474 326,066 72,023 72,124 95,051 150,293 176,285 (4,771) (18,933) (23,411) (25,440) 67,252 72,124 76,118 126,882 150,845 (2,089) (3,156) 67,252 70,035 72,962 126,882 150,845 26,881 56,214 29,346 67,252 70,096 73,559 125,282 150,102 (232) (61) (597) 1,600 743 67,020 70,035 72,962 126,882 150,845 (B) 資產及負債 權益 472,799 781,181 925,202 1,101,692 1,381,344 (79,949) (280,011) (354,345) (269,890) (361,314) 392,850 501,170 570,857 831,802 1,020,030 383,868 492,249 568,094 827,439 1,014,924 8,982 8,921 2,763 4,363 5,106 392,850 501,170 570,857 831,802 1,020,030 5 103
Mingyuan Medicare Development Company Limited Annual Report 2008 The Mingyuan Network Mingyuan head office Hong Kong HEALTHDIGIT head office Shanghai representative office Beijing Shanghai Factory C-12 Shanghai fengxian huzhou HPV SHENZHEN C-12 product China distribution C-12 Harbin URUMQI changchun shenyang beijing TIANJIN SHIJIAZHUANG taiyuan ZHENGZHOU XIAN LUOYANG HANGZHOU JINAN HEFEI NANCHANG NANJING Shanghai shenzhen FUZHOU haikou CHENGDU CHONGQING wuhan changsha KUNMING HOHHOT C-12 product Overseas distribution C-12 Malaysia THAILAND singapore brunei philippines indonesia
二零零八年年報 The Mingyuan Network 33.9% other 其它 22.5% Heart Diseases 心臟病 (ICD-9 codes 390-398 and 401 429) Total 總計 :4,459 (22.5%) men 男性 :2,489 (22%) Woman 女性 : 2,017 (23.1%) Major Causes of Death in China 中國主要致命疾病 : 3 Leading Causes of Death in China with population aged over 40 中國 40 歲以上人士的三大致命疾病 * The causes of death were coded according to the International Classification of Diseases, Ninth Revision (ICD-9). 致命疾病乃按國際病症分類法第九版 (ICD-9) 編碼 21.3% Cerebrovascular Diseases 腦血管病 (ICD-9 codes 430 438) Total 總計 :4,260 (21.3%) men 男性 :2,446 (21.6%) Woman 女性 : 1,814 (20.8%) 22.3% Cancer 癌病 (ICD-9 codes 140 208) Total 總計 :4,459 (22.3%) men 男性 :2,833 (25%) Woman 女性 : 1,626 (18.6%) The three leading causes of death (Heart Diseases, Cancer & Cerebrovascular Disease) accounted for 66.1% of deaths from all causes. Others include infectious diseases, respiratory diseases and diabetes etc. 三大致命疾病 ( 即心臟病 癌症及腦血管病 ) 佔總死亡人數 66.1%, 而其他致命疾病包括傳染病 呼吸道疾病及糖尿病等 Mortality for the Five Leading Causes of Death from Cancer WITH POPULATION AGED OVER 40 (MEN): 40 歲以上人士的五大致命癌症死亡率 ( 男性 ): other 其他 18% colon & rectum 結腸及直腸癌 5.2% esophagus 食道癌 11.7% Lung 肺癌 25.9% stomach 胃癌 17.5% Liver 肝癌 21.7% Other 其他 20.1% breast 乳癌 5.2% colon & rectum 結腸及直腸癌 7.2% uterus 子宮癌 8.4% esophagus 食道癌 8.9% Lung 肺癌 21.8% stomach 胃癌 14.9% Liver 肝癌 13.5% Mortality for the Five Leading Causes of Death from Cancer with population aged over 40 (women) : 40 歲以上人士的五大致命癌症死亡率 ( 女性 ): Source : 資料來源 : Major Causes of Death among Men and Women in China dated 15 Sep 2005 from The New England Journal of Medicine The New England Journal of Medicine 二零零五年九月十五日發表的 Major Causes of Death among Men and Women in China 1